藏药组合方案治疗高原地区新型冠状病毒感染341例  

Clinical observation of 341 cases of COVID-19 infection treated with a Tibetan medicine combination regimen in plateau regions

作　　者：多杰太 格桑云旦 张琼文 平措多吉 王保 索朗仁青 桑旦 沈燕如 李延军 仁青加 丹松扎巴 边巴次仁 唐健元 陈维武 DUO Jie-tai;GESANG Yun-dan;ZHANG Qiong-wen;PINGCUO Duo-ji;WANG Bao;SUOLANG Ren-qing;SANG Dan;SHEN Yan-ru;LI Yan-jun;REN Qing-jia;DANSONG Zha-ba;BIANBA Ci-ren;TANG Jian-yuan;CHEN Wei-wu(Xizang Fukang Hospital,Lasha 850099,China;Xizang Cheezheng Tibetan Medicne Co.,Ltd.,Linzhi 860000,China;Lintao Cheezheng Tibetan Hospital,Lintao 730599,China;Xizang University of Tibetan Medicine,Lasha 850007,China;Suoxian Tibetan Medicine Hospital,Suoxian 852200,China;Xizang Yuzheng Health Technology Co.,Ltd.,Lasha 850032,China;The Hospital of Chengdu University of Traditional Chinese Medicine,Chengdu 730599,China)

机构地区：[1]西藏阜康医院,拉萨850099 [2]西藏奇正藏药股份有限公司,林芝860000 [3]临洮县奇正藏医医院,临洮730599 [4]西藏藏医药大学,拉萨850007 [5]索县藏医院,索县852200 [6]西藏宇正健康科技有限公司,拉萨850032 [7]成都中医药大学附属医院,成都730599

出　　处：《中国新药杂志》2025年第3期275-281,共7页Chinese Journal of New Drugs

基　　金：国家中医药管理局“新型冠状病毒感染肺炎中医药应急专项”资助项目(2022ZYLCYJ09-2);西藏自治区藏医药管理局“呼吸道病毒感染的防治养系列藏药研发”资助项目(JJKT2020025)。

摘　　要：目的:观察藏药组合方案对高原地区人群感染新型冠状病毒轻症患者核酸转阴率及症状消失率的影响。方法:试验纳入方舱患者653例,根据患者住舱区域和服药意愿分为藏药组(催汤颗粒+流感丸+仁青芒觉胶囊+达斯玛保丸)和对照组(未服用藏药),治疗后评估核酸转阴率和症状消失率。结果:藏药组在核酸转阴率和住舱时间上与对照组无明显差异(P>0.05),在发热、咳嗽、头痛、咽干咽痛、鼻塞、乏力等方面疗效优于对照组(P<0.01)。结论:藏药组合方案在缓解发热、咳嗽、头痛、咽痛、鼻塞等新型冠状病毒感染引起的症状方面有一定优势。Objective:To investigate the effect of Tibetan medicine combination regimen on the rates of negative nucleic acid conversion and symptom resolution in mild COVID-19 patients in plateau regions.Methods:A total of 653 patients were involved in the study and were assigned to either Tibetan medicine group(Cuitang granules+Liugan pills+Renqing Mangjue capsules+DasiMabao pills)or the Control group(no Tibetan medicine),based on theor willingness to received treatment.The rates of negative nucleic acid conversion and symptom remission were evaluated following the intervension.Results:There was no significant difference in the negative nucleic acid conversion rate and duration of residence between the Tibetan medicine and the Control group(no Tibetan medicine)(P>0.05).However,the therapeutic effects of Tibetan medicine were better than those of Control group in alleviating symptoms of fever,cough,headache,dry pharyngeal pain,nasal congestion,fatigue and other related aspects(P<0.01).Conclusion:The combination regimen of Tibetan medicine offers distinct advantages in relieving symptoms associated with novel coronavirus infection,including fever,cough,headache,sore throat and nasal congestion.

关 键 词：藏药组合方案 新型冠状病毒感染 高原地区 临床观察 

分 类 号：R969.6[医药卫生—药理学]